A recently published study by Ulf Eriksson's research group at the Department of Medical Biochemistry and Biophysics at Karolinska Institutet shows that elevated levels of the protein VEGF-B in ...
This inactivation ultimately causes increased secretion of VEGF. 1 Two phase III studies—Avastin for Renal Cell Cancer (AVOREN) 7 and Cancer and Leukemia Group B (CALGB) 90206 8 indicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback